I didn't see if this was posted because I have all of the other posters here on Ignore - got this in my email this morning from PennyStockRumors.net. They claim not to have been compensated for it, which I guess means they were just unloading stock.
New Penny Alert: NEUN
----------------------------------------------------------------
Good morning readers and welcome new subscribers.
The market opens in less than 10 minutes so we will jump right into it! Today's alert is a low float (46M shares) penny play that could see a huge spark of momentum this morning.
The company even put out a press release this morning which should draw even more attention to this hidden gem!
Our new penny play is:
NEUN - NeuroGenesis Inc.
NEUN engages in the development of a series of products to be used as adjuncts to therapy by the substance-abuse treatment community. Neurotransmitters are chemicals that allow communication to occur in the brain.
NEUN offers NeuBecalm'd, a nutritional supplement to reduce the effects of acute and chronic stress factors; NeuBecalm'd Chewables that reduces the effects of stress; and NeuRecover, a nutritional support for the natural replenishment of neurotransmitters depleted by the long-term use of alcohol.
NEUN also provides NeuRelieve, a nutritional support for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the long-term use of anti-anxiety drugs, and to be used in conjunction with professional support during the tapering process; NeuReplenish for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the long-term use of chemical stimulants; and NeuSlim, which aids in the reduction of cravings (or urges) for simple carbohydrates, to reduce excessive appetite in general, and to assist in healthy moderation of nutritional needs.
NEUN markets its products to rehabilitation hospitals and clinics worldwide. The company was founded in 1984 and headquartered in League City, Texas.
Supplements Market Could Reach $204B by 2017
A new market report from Transparency Market Research, Albany, NY, has found that the global nutraceutical product market reached $142.1 BLN in 2011 and is expected to reach $204.8B by 2017, growing at a CAGR of 6.3 Pct. from 2012 to 2017. Asia Pacific (including Japan) is expected to have the second largest market share after North America by 2017.
The report, “Nutraceuticals Product Market: Global Market Size, Segment and Country Analysis & Forecasts (2007-2017),” also cited that in 2011, the functional food and beverage market reached $93.0B, registering a growth rate of 6.0 Pct. from 2007 to 2011. North America enjoyed the highest market share for nutraceutical products at $56.4B in 2011.
According to Transparency Market Research, the global nutraceutical market is growing primarily on account of growth in dietary supplement segment, however functional foods and beverages also make up a significant market segment. North America has the highest market share for nutraceutical product market, which is primarily supported by the U.S. health conscious consumers segment.
The global nutraceutical market is estimated to have a growth rate of 6.6 Pct. during the forecasted period (2012-2017) in protein and peptides segment of dietary supplement market. The non-herbal segment of dietary supplement market will have a growth rate of 6.3 Pct. from 2012 to 2017. The omega fatty acid fortified food segment of functional food market will have a growth rate of 6.7 Pct. during the forecasted period.
The North America and Asia Pacific nutraceutical market is expected to have a market share of 39.2 Pct. and 30.4 Pct. respectively in 2017. The dietary supplement market will be the fastest growing market from 2012 to 2017 as it helps in improving the body ability to heal and protect itself.
The company issued a new PR this morning too!
NeuroGenesis Dietary Supplements Are Covered by Issued Patents
LEAGUE CITY, TX- November 21, 2013- NeuroGenesis, Inc. has been marketing and selling a variety of patented supplements into the large supplement marketplace for over 25 years. The Company's products range from Neu BeCalm'd (beneficial for relief of stress; improves mental focus and concentration; helps establish normal sleep patterns) to NeuRelieve (supplements to replenish neurotransmitters depleted by benzodiazepine), NeuRecover (supplements to replenish neurotransmitters depleted by alcohol), NeuReplenish (supplements to replenish neurotransmitters depleted by use of chemical stimulants) and NeuSlim (provides nutritional support for healthy weight loss and maintenance). With over 30 years of scientific research and clinical studies and use in over 1,700 US hospitals and drug rehab centers.
The Company currently has three "use" patents that relate to the ingredients in NeuroGenesis products. A "use" patent is the exclusive right to use a substance in a specific way. You can find more information on the Company's website at: www.neurogenesis.com.
You can read the full PR here.
As you can see, NEUN is like nothing we've came across in the past. This company has the rights to patents, made over 100k in sales last quarter, and is a profitable pinksheet company. The number of companies that fit that criteria is extremely low, and that is why NEUN deserves your full attention today.
Make sure you're watching NEUN this morning!
